Serum prolidase, urotensin-2 and nesfatin levels in patients with compensated or uncompensated cirrhosis (Annals of Medical Research, 2019;26(8):1666-1669)

Authors

  • Ferzan Aydin Harran University, Faculty of Medicine, Department of Internal Medicine, Sanliurfa, Türkiye
  • Cigdem Cindoglu Harran University, Faculty of Medicine, Department of Internal Medicine, Sanliurfa, Türkiye
  • Idris Kirhan Harran University, Faculty of Medicine, Department of Internal Medicine, Sanliurfa, Türkiye
  • Ahmet Uyanikoglu Harran University, Faculty of Medicine, Deaprtment of Gastroenterelogy, Sanliurfa, Türkiye
  • Necati Yenice Harran University, Faculty of Medicine, Deaprtment of Gastroenterelogy, Sanliurfa, Türkiye

Keywords:

None

Abstract

None

Downloads

Download data is not yet available.

Downloads

Published

2024-09-26

Issue

Vol. 31 No. 9 (2024): September

Section

Erratum

License

Copyright (c) 2024 Annals of Medical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

CC Attribution-NonCommercial-NoDerivatives 4.0

How to Cite

1.
Serum prolidase, urotensin-2 and nesfatin levels in patients with compensated or uncompensated cirrhosis (Annals of Medical Research, 2019;26(8):1666-1669). Ann Med Res [Internet]. 2024 Sep. 26 [cited 2025 Feb. 23];31(9):757. Available from: http://annalsmedres.org/index.php/aomr/article/view/4734